Title : Fyn kinase inhibition as a novel therapy for Alzheimer's disease.

Pub. Date : 2014

PMID : 24495408






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We are currently enrolling patients in a phase Ib study of saracatinib (AZD0530), a small molecule inhibitor with high potency for Src and Fyn, for the treatment of AD. saracatinib SRC proto-oncogene, non-receptor tyrosine kinase Homo sapiens
2 We are currently enrolling patients in a phase Ib study of saracatinib (AZD0530), a small molecule inhibitor with high potency for Src and Fyn, for the treatment of AD. saracatinib SRC proto-oncogene, non-receptor tyrosine kinase Homo sapiens